Nukute is a forward-thinking startup focused on developing advanced medical devices for the screening and diagnosis of Sleep Apnea, a common sleep disorder. The company collaborates with leading sleep disorder experts, university hospitals, and industry partners worldwide to ensure their products are at the cutting edge of technology and meet stringent medical device regulations and standards.

Nukute operates in the healthcare and medical device market, specifically targeting the sleep disorder segment. Their primary clients include healthcare providers such as hospitals, sleep clinics, and medical professionals who specialize in diagnosing and treating sleep disorders. By providing these clients with reliable and effective diagnostic tools, Nukute aims to improve patient outcomes and streamline the diagnostic process.

The business model of Nukute revolves around the development, production, and sale of medical devices. These devices are designed to be used in clinical settings to diagnose Sleep Apnea accurately. The company generates revenue through the direct sale of these devices to healthcare institutions and through partnerships with other industry players. Additionally, they may also earn income from service agreements, maintenance contracts, and potential licensing deals.

Nukute's products are CE marked, which means they meet the European Union's safety, health, and environmental protection requirements, ensuring they are safe and effective for clinical use. This compliance is crucial for gaining trust and acceptance in the medical community.

In 2017, Nukute was recognized by the EU Horizon 2020, a significant research and innovation program, which highlights the company's potential and innovative approach in the medical device industry.

Keywords: Sleep Apnea, medical devices, healthcare, diagnostics, innovation, CE marked, EU Horizon 2020, sleep disorder, clinical use, partnerships.